"
Team:Potsdam Bioware
From 2012.igem.org
(Difference between revisions)
| (5 intermediate revisions not shown) | |||
| Line 5: | Line 5: | ||
== Antibody Generation System - Maturation, Selection and Production in CHO Cells == | == Antibody Generation System - Maturation, Selection and Production in CHO Cells == | ||
=== Project Description === | === Project Description === | ||
| - | Antibodies are of utmost importance for research and therapy but their generation is laborious and time consuming. We established a novel streamlined workflow for obtaining antibodies by incorporating all natural steps such as antibody maturation, selection and production in one genetic system implemented into a eukaryotic cell line. We stably transfect an antibody construct into CHO cells and mimic maturation by using the enzyme AID (activation-induced deaminase), which is known to induce somatic hypermutation. For selection, we are testing and deploying a versatile and continuous viral system as well as magnetic beads and cell sorting. Finally, a genetic switch enables the transition from surface expression to production of soluble antibodies. In addition, we pursue phage display with an antibody fragment to study mutation rate and evolution by AID in prokaryotes. Our system supersedes animal immunization | + | Antibodies are of utmost importance for research and therapy but their generation is laborious and time consuming. We established a novel streamlined workflow for obtaining antibodies by incorporating all natural steps such as antibody maturation, selection and production in one genetic system implemented into a eukaryotic cell line. We stably transfect an antibody construct into CHO cells and mimic maturation by using the enzyme AID (activation-induced deaminase), which is known to induce somatic hypermutation. For selection, we are testing and deploying a versatile and continuous viral system as well as magnetic beads and cell sorting. Finally, a genetic switch enables the transition from surface expression to production of soluble antibodies. In addition, we pursue phage display with an antibody fragment to study mutation rate and evolution by AID in prokaryotes. Our system supersedes animal immunization and the smooth process will increase the ready availability of antibodies in various formats. |
</div> | </div> | ||
<html> | <html> | ||
| Line 18: | Line 18: | ||
</div> | </div> | ||
<div id="second_row"> | <div id="second_row"> | ||
| - | <a id="rollover-image-7" href="https://2012.igem.org/Team:Potsdam_Bioware/Biobricks"></a> | + | <a id="rollover-image-7" href="https://2012.igem.org/Team:Potsdam_Bioware/Biobricks/Overview"></a> |
<a id="rollover-image-6" href="https://2012.igem.org/Team:Potsdam_Bioware/Project/Potsdam%20Standard"></a> | <a id="rollover-image-6" href="https://2012.igem.org/Team:Potsdam_Bioware/Project/Potsdam%20Standard"></a> | ||
<a id="rollover-image-5" href="https://2012.igem.org/Team:Potsdam_Bioware/SocialBrick"></a> | <a id="rollover-image-5" href="https://2012.igem.org/Team:Potsdam_Bioware/SocialBrick"></a> | ||
| Line 29: | Line 29: | ||
| - | <div class="box_round | + | <div class="box_round no_padding"> |
{{:Team:Potsdam_Bioware/slider}} | {{:Team:Potsdam_Bioware/slider}} | ||
</div> | </div> | ||
| Line 37: | Line 37: | ||
<div id="clustrmaps-widget"> | <div id="clustrmaps-widget"> | ||
</div><script type="text/javascript">var _clustrmaps = {'url' : 'https://2012.igem.org/Team:Potsdam_Bioware', 'user' : 1035150, 'server' : '4', 'id' : 'clustrmaps-widget', 'version' : 1, 'date' : '2012-09-22', 'lang' : 'en', 'corners' : 'square' };(function (){ var s = document.createElement('script'); s.type = 'text/javascript'; s.async = true; s.src = 'http://www4.clustrmaps.com/counter/map.js'; var x = document.getElementsByTagName('script')[0]; x.parentNode.insertBefore(s, x);})();</script><noscript><a href="http://www4.clustrmaps.com/user/3d4fcb8e"><img src="http://www4.clustrmaps.com/stats/maps-no_clusters/2012.igem.org-Team-Potsdam_Bioware-thumb.jpg" alt="Locations of visitors to this page" /></a></noscript> | </div><script type="text/javascript">var _clustrmaps = {'url' : 'https://2012.igem.org/Team:Potsdam_Bioware', 'user' : 1035150, 'server' : '4', 'id' : 'clustrmaps-widget', 'version' : 1, 'date' : '2012-09-22', 'lang' : 'en', 'corners' : 'square' };(function (){ var s = document.createElement('script'); s.type = 'text/javascript'; s.async = true; s.src = 'http://www4.clustrmaps.com/counter/map.js'; var x = document.getElementsByTagName('script')[0]; x.parentNode.insertBefore(s, x);})();</script><noscript><a href="http://www4.clustrmaps.com/user/3d4fcb8e"><img src="http://www4.clustrmaps.com/stats/maps-no_clusters/2012.igem.org-Team-Potsdam_Bioware-thumb.jpg" alt="Locations of visitors to this page" /></a></noscript> | ||
| - | </center> | + | |
| - | </html> | + | <font size="-4"; color="grey">primary contact: Kristian Müller<br> |
| + | <a href="http://www.syntbio.net"> http://www.syntbio.net</a> <a href="mailto:kristian@syntbio.net">kristian@syntbio.net</a></font></center></html> | ||
Latest revision as of 13:32, 16 November 2012
Antibody Generation System - Maturation, Selection and Production in CHO Cells
Project Description
Antibodies are of utmost importance for research and therapy but their generation is laborious and time consuming. We established a novel streamlined workflow for obtaining antibodies by incorporating all natural steps such as antibody maturation, selection and production in one genetic system implemented into a eukaryotic cell line. We stably transfect an antibody construct into CHO cells and mimic maturation by using the enzyme AID (activation-induced deaminase), which is known to induce somatic hypermutation. For selection, we are testing and deploying a versatile and continuous viral system as well as magnetic beads and cell sorting. Finally, a genetic switch enables the transition from surface expression to production of soluble antibodies. In addition, we pursue phage display with an antibody fragment to study mutation rate and evolution by AID in prokaryotes. Our system supersedes animal immunization and the smooth process will increase the ready availability of antibodies in various formats.
primary contact: Kristian Müllerhttp://www.syntbio.net kristian@syntbio.net
